NorthRock Partners’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Buy |
9,181
+2,245
| +32% | +$116K | 0.01% | 413 |
|
|
2025
Q1 | $407K | Buy |
6,936
+277
| +4% | +$16.2K | 0.01% | 396 |
|
|
2024
Q4 | $480K | Buy |
6,659
+610
| +10% | +$43.9K | 0.02% | 366 |
|
|
2024
Q3 | $483K | Buy |
6,049
+60
| +1% | +$4.8K | 0.02% | 370 |
|
|
2024
Q2 | $429K | Buy |
5,989
+555
| +10% | +$39.8K | 0.02% | 377 |
|
|
2024
Q1 | $382K | Buy |
5,434
+79
| +1% | +$5.56K | 0.01% | 420 |
|
|
2023
Q4 | $413K | Buy |
5,355
+1,812
| +51% | +$140K | 0.02% | 375 |
|
|
2023
Q3 | $241K | Sell |
3,543
-667
| -16% | -$45.4K | 0.03% | 283 |
|
|
2023
Q2 | $344K | Sell |
4,210
-177
| -4% | -$14.4K | 0.04% | 192 |
|
|
2023
Q1 | $325K | Buy |
4,387
+82
| +2% | +$6.08K | 0.03% | 209 |
|
|
2022
Q4 | $357K | Buy |
4,305
+837
| +24% | +$69.4K | 0.04% | 214 |
|
|
2022
Q3 | $246K | Buy |
3,468
+76
| +2% | +$5.39K | 0.03% | 247 |
|
|
2022
Q2 | $294K | Sell |
3,392
-784
| -19% | -$68K | 0.03% | 220 |
|
|
2022
Q1 | $452K | Buy |
4,176
+876
| +27% | +$94.8K | 0.04% | 187 |
|
|
2021
Q4 | $427K | Buy |
+3,300
| New | +$427K | 0.03% | 196 |
|